Navigation Links
Study Unblinded: ZYTIGA® (abiraterone acetate) Plus Prednisone for Asymptomatic or Mildly Symptomatic Chemotherapy-Naive Patients with Metastatic Castration-Resistant Prostate Cancer
Date:3/8/2012

nical symptoms or signs suggestive of hepatotoxicity develop. Elevations of AST, ALT, or bilirubin from the patient's baseline should prompt more frequent monitoring. If at any time AST or ALT rise above five times the upper limit of normal (ULN) or the bilirubin rises above three times the ULN, interrupt ZYTIGA® treatment and closely monitor liver function.

Food Effect - ZYTIGA® must be taken on an empty stomach. Exposure of abiraterone increases up to 10-fold when abiraterone acetate is taken with meals. No food should be eaten for at least two hours before the dose of ZYTIGA® is taken and for at least one hour after the dose of ZYTIGA® is taken. Abiraterone Cmax and AUC0-infinity (exposure) were increased up to 17- and 10-fold higher, respectively, when a single dose of abiraterone acetate was administered with a meal compared to a fasted state.

Adverse Reactions - The most common adverse reactions (greater than or equal to 5%) are joint swelling or discomfort, hypokalemia, edema, muscle discomfort, hot flush, diarrhea, urinary tract infection, cough, hypertension, arrhythmia, urinary frequency, nocturia, dyspepsia, fractures and upper respiratory tract infection.

Drug Interactions - ZYTIGA® is an inhibitor of the hepatic drug-metabolizing enzyme CYP2D6. Avoid coadministration with CYP2D6 substrates that have a narrow therapeutic index. If an alternative cannot be used, exercise caution and consider a dose reduction of the CYP2D6 substrate. Additionally, abiraterone is a substrate of CYP3A4 in vitro. Strong inhibitors and inducers of CYP3A4 should be avoided or used with caution.

Use in Specific Populations - The safety of ZYTIGA® in patients with baseline severe hepatic impairment has not been studied. These patients should not receive ZYTIGA®.

About Janssen Research & Development, LLC

Janssen Research & Development, LLC is headquartere
'/>"/>

SOURCE Janssen Research & Development, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Germany , July 30, 2014  invendo ... and computer-assisted ("robotic") colonoscopy system, today announced the appointment ... medical device executive, as a new member of its ... highly respected global visionary in the medical device industry. ... and Chief Executive Officer at Given Imaging Ltd. (NASDAQ/TASE: ...
(Date:7/30/2014)... and PARIS , July 30, 2014 ... and Sanofi (EURONEXT: SAN and NYSE: SNY ... trials of alirocumab in people with hypercholesterolemia met their ... baseline in low-density lipoprotein cholesterol (LDL-C) at 24 weeks ... investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type ...
(Date:7/30/2014)... , July 30, 2014  DigiPath, Inc. (OTCBB ... is expanding into the cannabis testing and education markets, ... its business and affairs not previously disclosed or, to ... recent unusual market action. "We have noticed ... the last three trading days," said Steve Barbee ...
Breaking Medicine Technology:invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 2invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8DigiPath No New Corporate Developments 2
... Jan. 5, 2012  Isis Pharmaceuticals, Inc. (NASDAQ: ... Phase 1 study with ISIS-TTRRx.  The results demonstrated ... reductions of greater than 80 percent in transthyretin ... well tolerated with no significant adverse events.  ISIS-TTRRx ...
... (NASDAQ: AMRI ), a global contract services ... preferred provider agreement with BioPontis Alliance LLC. The agreement ... gap between early-stage research and technologies being discovered and ... provide its services in small molecule discovery, development, and ...
Cached Medicine Technology:ISIS Reports Phase 1 Data Demonstrating ISIS-TTRRx Produces Significant Reductions in TTR Protein 2ISIS Reports Phase 1 Data Demonstrating ISIS-TTRRx Produces Significant Reductions in TTR Protein 3ISIS Reports Phase 1 Data Demonstrating ISIS-TTRRx Produces Significant Reductions in TTR Protein 4AMRI Announces Preferred Provider Agreement with BioPontis Alliance LLC 2AMRI Announces Preferred Provider Agreement with BioPontis Alliance LLC 3
(Date:7/30/2014)... 30, 2014 Daily Gossip indicates in its ... easily. A panic attack is a feeling of intense stress ... are a series of symptoms that sufferers commonly deal with ... of breath, stress or anxiety. Naturally, panic attacks deeply affect ... way to overcome them. , The 60 Second Panic Solution ...
(Date:7/30/2014)... The Restore My Blood Sugar review recently ... sugar levels can now find an amazingly successful method of ... was created by D. Chao and Andrew Forester who claim ... when it comes to normalizing blood sugar levels. Chao actually ... secret to the cure of diabetes that all patients should ...
(Date:7/30/2014)... 30, 2014 Within weeks freshman will begin to ... Each hopes this will be a time of growth and the ... to pause; it may not be as easy as it looks. ... will switch their major at least once and many will switch ... and the costs are exacerbated when switching in the later years ...
(Date:7/30/2014)... July 30, 2014 Ticket Down ... Bayern Munich vs. Chivas Guadalajara friendly exhibition match at ... World Cup, the one team that was left standing as ... made it through the world’s largest football competition and even ... their way to the cup. Germany was led by seven ...
(Date:7/30/2014)... HealthDay Reporter WEDNESDAY, July 30, 2014 ... to develop dementia, but researchers have been unable to explain ... Specifically, they haven,t been able to figure out the direction ... on dementia, or does dementia cause people to become depressed? ... journal Neurology sheds more light on the mystery. ...
Breaking Medicine News(10 mins):Health News:60 Second Panic Solution Review Reveals Unique Way to Stop Panic Attacks 2Health News:Restore My Blood Sugar Review Reveals Exclusive Ways to Normalize Blood Sugar 2Health News:Advice to College Freshman from Author Garrett Miller 2Health News:Advice to College Freshman from Author Garrett Miller 3Health News:Bayern Munich vs. Chivas Guadalajara Tickets Red Bull Arena: Ticket Down Slashes Ticket Prices for Chivas Guadalajara vs. Bayern Munich in Harrison, NJ 2Health News:Bayern Munich vs. Chivas Guadalajara Tickets Red Bull Arena: Ticket Down Slashes Ticket Prices for Chivas Guadalajara vs. Bayern Munich in Harrison, NJ 3Health News:Scientists Shed Light on Link Between Depression, Dementia 2Health News:Scientists Shed Light on Link Between Depression, Dementia 3
... 16 A grassroots,effort to promote advance care planning ... than 450 participating organizations in,all 50 states. The first ... a year ago and implemented with no budget or,full-time ... am blown away by the response to our grassroots ...
... know anyone,who,s a Type-A personality? A multi-tasking, go-getter? ... would turn out to be Type-A.,There,s a lot ... But the antioxidants,deserve some special attention., (Photo: ... food by their deep-colored pigment - such as ...
... thinking skills, study finds , , WEDNESDAY, April 16 (HealthDay News) ... than women to develop mild cognitive impairment, new research shows. ... found more women than men [or an equal proportion] have ... men," study author Rosebud Roberts, of the Mayo Clinic in ...
... Abstract 19, Study highlights:, -- Low ... prevalence,of peripheral arterial disease (PAD) in a study that ... feel this needs further study and do not recommend,people ... by,their doctors., -- The American Heart Association recommends ...
... patient care while ... saving Medicaid dollars, ... Best Practices in Consumer Empowerment and,Protection Awards competition, naming the ... Eli Lilly,and Company as Silver Award winners in the Health ...
... Challenges Facing the ... Healthcare Industry, ... association with U.S. News & World Report,hosted an exclusive panel ... the National Press Club in Washington, D.C.,The event, attended by ...
Cached Medicine News:Health News:More Than 350 Events Today in Recognition of First National Healthcare Decisions Day 2Health News:Cranberries: The Little Fruit With a Great Big Punch 2Health News:Cranberries: The Little Fruit With a Great Big Punch 3Health News:Low Vitamin D Levels Associated With an Increased Risk of Peripheral Arterial Disease 2Health News:Low Vitamin D Levels Associated With an Increased Risk of Peripheral Arterial Disease 3Health News:Mental Health Prescription Program Named Winner in URAC's Best Practices in Consumer Empowerment and Protection Awards 2Health News:Mental Health Prescription Program Named Winner in URAC's Best Practices in Consumer Empowerment and Protection Awards 3Health News:Mental Health Prescription Program Named Winner in URAC's Best Practices in Consumer Empowerment and Protection Awards 4Health News:Siemens Addresses Cost vs. Value Issues In Healthcare and Technology 2Health News:Siemens Addresses Cost vs. Value Issues In Healthcare and Technology 3
Inquire...
Bench Top Class I Containment Cabinet Personnel Protection...
Inquire...
... internal calibration mass for convenient ... of Fully Automatic Self-Calibration at ... changes are detected, or touch-key ... RS232 Interface, Shimadzu WindowsDirect communication ...
Medicine Products: